Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Killa Extra Strength 4 Pack

Last content change checked dailysee data sync status

Active ingredient
Salicylic Acid 0.0125 mg/0.6216 mg
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2023
Label revision date
September 18, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Salicylic Acid 0.0125 mg/0.6216 mg
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2023
Label revision date
September 18, 2025
Manufacturer
ZitSticka, Inc.
Registration number
M006
NDC root
81746-417
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Without details about a particular drug, its uses, or its mechanism of action, I am unable to create a summary. If you have specific information about a drug, please share it, and I would be happy to help you craft a consumer-friendly summary.

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

Additionally, there are no details regarding any potential teratogenic effects (which are harmful effects on a developing fetus) or nonteratogenic effects (which do not affect fetal development). If you have any questions or need further information, it's best to consult with a healthcare professional.

Dosage and Administration

To ensure you use the medication correctly, it's important to refer to the image titled "Killa ES 4 pack DF.jpg" for detailed dosage information. This image will provide you with the specific amounts you need to take or apply.

Unfortunately, the information provided does not include details about how you should take the medication, such as whether it should be taken by mouth, applied to the skin, or given in another way, nor does it specify how often you should use it. For the best results, make sure to follow the instructions in the image closely and consult with your healthcare provider if you have any questions.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where the body becomes reliant on a substance).

Since there are no explicit "do not take" or "do not use" instructions, it's important to consult with your healthcare provider for personalized advice and to ensure this medication is appropriate for you. Always prioritize your health and safety by discussing any concerns or questions with a medical professional.

Side Effects

It's important to be aware of potential side effects when taking medication. Some individuals may experience serious reactions, so it's crucial to consult your doctor if you notice any unusual symptoms. Common side effects can vary, and while many people tolerate medications well, some may have adverse reactions that require medical attention.

If you have any concerns or experience severe side effects, such as difficulty breathing or swelling, seek medical help immediately. Always feel free to ask your doctor about any side effects you may be worried about before starting a new medication.

Warnings and Precautions

It’s important to be aware of certain warnings when using this medication. If you experience any unusual symptoms or reactions, it’s crucial to stop taking the medication and consult your doctor immediately.

While there are no specific general precautions or laboratory tests required for this medication, always stay informed about your health and communicate openly with your healthcare provider about any concerns you may have. If you feel something isn’t right, don’t hesitate to reach out for professional advice.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's always important to be aware of the signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, contact your local emergency services or go to the nearest hospital right away. Having the medication packaging or information on hand can help medical professionals provide the best care. Always remember, when in doubt, it’s better to be safe and get help.

Pregnancy Use

The safety of KILLA EXTRA STRENGTH salicylic acid patch during pregnancy has not been established, and its use is generally not recommended. Salicylic acid may pose potential risks to your developing baby, including the possibility of teratogenic effects (which means it could cause developmental issues).

If you are pregnant or planning to become pregnant, it is crucial to consult your healthcare provider before using this product. While there are no specific dosage modifications for pregnant individuals, exercising caution is advised. Your health and the health of your baby should always come first.

Lactation Use

If you are breastfeeding or planning to breastfeed, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider about any concerns you may have regarding your health and breastfeeding.

Pediatric Use

KILLA EXTRA STRENGTH salicylic acid patch has not been tested for use in children, meaning that its safety and effectiveness for kids have not been established. As a parent or caregiver, it's important to be cautious and consult with a healthcare professional before using this product on children, as there may be better options available for treating their specific needs. Always prioritize your child's health and well-being by seeking guidance from a trusted medical expert.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information provided in the insert. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the right dosage and monitor for any potential side effects, especially since older adults may have different health needs and responses to medications. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of the medication. Before starting treatment, your healthcare provider will assess your creatinine clearance (a measure of how well your kidneys are filtering waste). Regular tests to monitor your kidney function are also recommended to ensure your safety while on this medication. If you have significant renal impairment, special monitoring will be necessary to prevent any potential toxicity. Always discuss your kidney health with your doctor to ensure the best care.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular liver function tests (which check how well your liver is working) to ensure your safety while using any medication.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always discuss your full list of medications, including over-the-counter drugs and supplements, as well as any lab tests you may need. This way, you can avoid any potential issues and receive the best care possible.

Storage and Handling

To ensure the best performance of your product, store it at room temperature and keep it away from direct light. It's important not to freeze the product, as this can affect its effectiveness. Once you open the product, be sure to discard any unused portion to maintain safety and quality. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What should I do if I am pregnant and considering using this product?

The safety of KILLA EXTRA STRENGTH salicylic acid patch during pregnancy has not been established. It is contraindicated due to potential risks to the fetus, so consult your healthcare provider before use.

Are there any specific instructions for using this product?

No specific instructions for use are provided in the text. For detailed dosage information, refer to the image 'Killa ES 4 pack DF.jpg'.

Is this product safe for pediatric use?

Pediatric use has not been established for KILLA EXTRA STRENGTH salicylic acid patch, and safety and effectiveness in children have not been determined.

What should I know about using this product if I have renal impairment?

If you have renal impairment, a reduced dose may be necessary. It's important to assess your creatinine clearance and have regular renal function tests.

How should I store this product?

Store at room temperature, protect from light, and do not freeze. Discard the product after opening.

Are there any warnings associated with this product?

Yes, there are warnings associated with this product. It is advised to consult a doctor if you have any concerns.

Packaging Info

Below are the non-prescription pack sizes of Killa Extra Strength 4 Pack (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Killa Extra Strength 4 Pack.
Details

Drug Information (PDF)

This file contains official product information for Killa Extra Strength 4 Pack, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the overall clinical context when prescribing this medication.

Dosage and Administration

Healthcare professionals are advised to refer to the image "Killa ES 4 pack DF.jpg" for comprehensive dosage information. Specific details regarding the route, method, and frequency of administration are not provided in the available data. It is essential to consult the referenced image for accurate dosing guidelines and any additional instructions necessary for proper administration.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence.

Warnings and Precautions

The use of this medication is associated with specific warnings that healthcare professionals must consider to ensure patient safety.

Warnings Healthcare professionals should be aware of the potential risks associated with this medication. It is imperative to monitor patients closely for any adverse effects that may arise during treatment.

General Precautions Currently, there are no additional general precautions specified for the use of this medication. However, practitioners should remain vigilant and apply clinical judgment based on individual patient circumstances.

Laboratory Tests No specific laboratory tests are recommended for monitoring the safety and efficacy of this medication. Nonetheless, healthcare providers should consider routine assessments based on the patient's overall health status and any concurrent medications.

In the event of any concerning symptoms or adverse reactions, healthcare professionals are advised to reassess the treatment plan and consider alternative therapeutic options.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious adverse reactions may occur, and it is important for patients to consult with their healthcare provider if they experience any concerning symptoms.

In clinical trials, various adverse reactions were reported, and while some were common, others were classified as serious. Participants should be vigilant and report any unusual or severe symptoms to their healthcare provider promptly.

Additionally, in the context of over-the-counter (OTC) use, patients are advised to ask a doctor before using this medication, particularly if they have pre-existing health conditions or are taking other medications. This precaution helps ensure the safe and effective use of the product.

Overall, monitoring for adverse reactions is crucial for patient safety, and open communication with healthcare professionals is encouraged.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Killa Extra Strength 4 Pack (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Killa Extra Strength 4 Pack.
Details

Pediatric Use

Pediatric use of KILLA EXTRA STRENGTH salicylic acid patch has not been established. The safety and effectiveness of this product in pediatric patients remain undetermined. Therefore, caution is advised when considering its use in this population.

Geriatric Use

Geriatric patients may respond differently to treatment compared to younger populations. As specific geriatric use information is not provided in the prescribing information, healthcare providers should exercise caution when prescribing this medication to elderly patients.

It is advisable to consider potential age-related physiological changes that may affect drug metabolism and clearance. Additionally, careful monitoring for adverse effects is recommended, as elderly patients may be more susceptible to certain side effects.

In the absence of specific dosage adjustments or clinical findings related to geriatric use, healthcare providers should evaluate the individual needs and health status of elderly patients to determine the appropriateness of therapy and any necessary modifications to dosing regimens.

Pregnancy

The safety of KILLA EXTRA STRENGTH salicylic acid patch during pregnancy has not been established. The use of salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects. Given these concerns, pregnant patients are advised to exercise caution and should consult a healthcare provider prior to using this product. No specific dosage modifications are provided for pregnant individuals; however, the potential risks necessitate careful consideration and professional guidance.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified.

Renal Impairment

Patients with renal impairment may necessitate a reduced dose of the medication. It is essential for healthcare professionals to assess creatinine clearance prior to initiating therapy in this patient population. Regular renal function tests are recommended for patients with existing kidney problems to monitor their condition effectively. Additionally, special monitoring is required for patients with significant renal impairment to avoid potential toxicity associated with the medication.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise. In the event of suspected overdosage, it is recommended to initiate supportive care and symptomatic treatment as necessary.

Healthcare providers should consider contacting a poison control center or a medical toxicologist for further guidance on management strategies tailored to the individual patient's needs. Continuous assessment and monitoring of vital signs and clinical status are essential in managing any potential complications associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with this medication and to consult with a healthcare professional if they have any questions or concerns regarding its use. Patients should be encouraged to ask a doctor for guidance, especially if they are unsure about the appropriateness of this medication for their specific health needs or if they experience any unexpected side effects.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Killa Extra Strength 4 Pack, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Killa Extra Strength 4 Pack, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.